Aphria Inc.
TSX VENTURE : APH

Aphria Inc.

April 01, 2015 06:00 ET

Aphria Completes First Two Wholesale Shipments

LEAMINGTON, ONTARIO--(Marketwired - April 1, 2015) - Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE:APH) is pleased to announce that it has completed its first two wholesale shipments of medical marijuana, pursuant to the amendment of its license it announced last week.

"We have completed our first two commercial wholesale shipments of approximately 54,000 grams of medical marijuana," stated Vic Neufeld, President and Chief Executive Officer of Aphria. "We are excited to advance this next prong of our growth strategy as we believe that, based on our current cash costs, our secondary wholesale strategy will deliver gross margins in excess of fifty percent."

About Aphria

Aphria, a company continued under the laws of the Province of Ontario and based in Leamington, Ontario, is in the business of producing, supplying and selling medical marijuana pursuant to the Marihuana for Medical Purposes Regulations (the "MMPR"). Under the MMPR, Health Canada is responsible for the oversight of commercial medical marijuana growers such as Aphria. Aphria's common shares are listed on the TSX Venture Exchange under the ticker symbol "APH".

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "intend" and similar expressions. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the medical marijuana industry in Canada generally, income tax and regulatory matters; the ability of Aphria to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Neither the TSX Venture Exchange (the "Exchange") nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information

  • Aphria Inc.
    Vic Neufeld
    President and Chief Executive Officer
    (519) 791-0129

    Aphria Inc.
    Media, Corporate and Patient Enquiries
    1-844-427-4742